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Reactivation of the varicella zoster virus (VZV) increases during aging. Although the effects of VZV reactivation
are observed in the skin (shingles), the number and functional capacity of cutaneous VZV-speciﬁc T cells have
not been investigated. The numbers of circulating IFN-γ-secreting VZV-speciﬁc CD4+ T cells are signiﬁcantly
decreased in old subjects. However, other measures of VZV-speciﬁc CD4+ T cells, including proliferative capacity
to VZV antigen stimulation and identiﬁcation of VZV-speciﬁc CD4+ T cells with an major histocompatibility
complex class II tetramer (epitope of IE-63 protein), were similar in both age groups. The majority of T cells in the
skin of both age groups expressed CD69, a characteristic of skin-resident T cells. VZV-speciﬁc CD4+ T cells were
signiﬁcantly increased in the skin compared with the blood in young and old subjects, and their function was
similar in both age groups. In contrast, the number of Foxp3+ regulatory T cells and expression of the inhibitory
receptor programmed cell death -1 PD-1 on CD4+ T cells were signiﬁcantly increased in the skin of older humans.
Therefore, VZV-speciﬁc CD4+ T cells in the skin of older individuals are functionally competent. However, their
activity may be restricted by multiple inhibitory inﬂuences in situ.
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INTRODUCTION
Varicella zoster virus (VZV), an alphaherpes virus, is the
causative agent of chickenpox. After resolution of the initial
infection, VZV enters a latent phase within the dorsal root
ganglia. However, later in life VZV reactivation can occur,
causing herpes zoster (also known as shingles), which results
from virus shedding into the skin (Arvin, 1996; Goldblatt,
1998; Arvin, 2001). Although the skin is the major site that is
involved in VZV reactivation during shingles, it is not clear
whether this is related to changes in skin-resident
VZV-speciﬁc T cells in this tissue. The role of a subset of memory
cells in the skin, termed tissue-resident memory T cells (Trms),
which are poised to provide efﬁcient and rapid immunity in
this organ, has been described recently (Gebhardt et al., 2009;
Gebhardt et al., 2011; Jiang et al., 2012). These Trm cells have
been shown to be part of the ﬁrst line of defense against
herpes simplex virus or human papilloma virus infections
(Gebhardt et al., 2009; Masopust et al., 2010; Tang and
Rosenthal, 2010; Cuburu et al., 2012; Mackay et al., 2012).
The activation of these cells also enables the recruitment of
circulating antigen-speciﬁc T cells, which ampliﬁes the
response (Schenkel et al., 2013). Although most studies of
Trm have focused on CD8+ populations (especially in mice),
CD4+ Trm cells also reside in the skin (Clark et al., 2006;
Clark et al., 2012; Mueller et al., 2013). In addition to tissue-
resident Trm cells, the skin also contains recirculating
memory T cells that actively recirculate between blood, skin,
and lymphoid organs (Bromley et al., 2013; Clark et al., 2012;
Jiang et al., 2012). It has been proposed that nonmigrating
tissue-resident T cells express CD69, which was found to be
necessary for S1P1 downregulation and T-cell retention
(Carbone et al., 2013; Skon et al., 2013).
We have investigated quantitative and qualitative changes
in VZV-speciﬁc CD4+ T cells in the blood and skin in young
and old subjects and have shown that, although the numbers
of these cells were increased in the skin compared with the
blood, the capacity of these cells to secrete cytokines was not
altered by aging. The vast majority of T cells in the skin of
both young and old individuals expressed CD69, a marker for
tissue-resident memory T-cell populations (Gebhardt et al.,
2009; Clark et al., 2012; Jiang et al., 2012), suggesting that
VZV-speciﬁc CD4+ T cells in healthy skin may be Trm cells.
Although cutaneous VZV-speciﬁc T cells in old individuals
are functionally competent, previous studies have shown that
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these subjects have decreased ability to mount a recall antigen
response to cutaneous VZV antigen challenge (Levin et al.,
2003; Agius et al., 2009). Our results suggest that this decrease
in cutaneous VZV-speciﬁc immunity is not directly due to a
defect in CD4+ Trm cells in this tissue. Instead, external
inﬂuences such as the increased numbers of suppressive
regulatory T cells (Tregs; Agius et al., 2009; Seneschal et al.,
2012) and/or increased signalling through the inhibitory receptor
programmed cell death PD-1 (Zajac et al., 1998; Wherry, 2011),
which is highly expressed on skin-resident CD4+ T cells, may
create an inhibitory microenvironment that restricts effective
immune responses to VZV in the skin of older humans.
RESULTS
VZV-speciﬁc CD4+T cells in the blood during aging
We investigated the effect of increasing age on VZV-speciﬁc
CD4+ T-cell frequency by measuring IFN-γ and IL-2 responses
following overnight stimulation of peripheral blood mono-
nuclear cell (PBMC) with VZV lysate. A total of 133 donors
were analyzed (aged 20–91 years) and only donors serolo-
gically positive for VZV were included in the analysis.
Figure 1a (left panel) shows representative dot plots of IFN-γ
production for unstimulated and VZV-stimulated PBMCs
gated on CD3+CD4+ T cells. We found a signiﬁcant decrease
of IFN-γ-secreting cells during aging (Figure 1a right
panel, Po0.0001), conﬁrming previous reports (Asanuma
et al., 2000; Levin et al., 2003). We also examined the IL-2
responses to VZV of the donors analyzed (Supplementary
Figure S1 online) but found that host age did not signiﬁcantly
inﬂuence the frequency of IL-2-secreting cells.
We next investigated VZV-speciﬁc T-cell activity by assessing
the ability of PBMCs from young and old donors to proliferate
after VZV antigen stimulation in vitro (Figure 1b and c). After
6 days of stimulation with a range of concentrations of VZV
lysate (n=29 old and 26 young) the extent of proliferation
measured by 3H-thymidine uptake was found to be similar in
young and old subjects except at the lowest dose of VZV antigen
used (Figure 1b). Furthermore, there were no differences in the
proportions of cells expressing Ki67 3 days after VZV lysate
stimulation (4 μl ml−1) in vitro (Figure 1c). This indicates that the
decrease in VZV-speciﬁc cells, identiﬁed by IFN-γ secre-
tion in the peripheral blood compartment, does not represent
a global defect in the functional responses of these cells.
We also investigated the frequency of VZV-speciﬁc cells in
young and old subjects (Figure 1d) using a HLA-DRB1*1501-
restricted IE63 class II tetramer (Jones et al., 2007;
Vukmanovic-Stejic et al., 2013). No difference was observed
in the number of tetramer-positive VZV-speciﬁc CD4+ T cells
between the young and old individuals tested (Figure 1d). We
conﬁrmed that the tetramer staining was speciﬁc by showing
an absence of staining when a control tetramer (CLIP) was
used, and also when HLA DRB1*1501-negative individuals
were tested (data not shown; Vukmanovic-Stejic et al., 2013).
Effect of age on leukocyte populations and global gene
expression signatures in the skin
We investigated whether there were numerical or func-
tional differences in the T cells found in young and old skin.
We collected 5-mm punch biopsies from individuals of both
age groups and analyzed them by immunohistochemistry and
immunoﬂuorescence using antibodies speciﬁc for CD3, CD4,
CD11c, CD163, and Foxp3 (Figure 2a). No difference was
observed in the number of CD3+, CD4+, or CD8+ T cells with
age (Figure 2b, Table 1). The numbers of dermal dendritic
cells (CD11c) or macrophages (CD163; Zaba et al., 2007;
Zaba et al., 2008; Haniffa et al., 2009) were also unaffected
by increasing age (Figure 2b,Table 1). However, there were
signiﬁcantly increased numbers of CD4+Foxp3+ T cells in the
skin of old compared with young individuals, in agreement
with previous studies (Gregg et al., 2005; Lages et al., 2008;
Agius et al., 2009). This difference was also observed by ﬂow
cytometric analysis of skin-derived populations (Supplemen-
tary Figure S2A online). The increased proportion of Foxp3+
cells in old skin was signiﬁcantly correlated with a decrease in
memory CD4+ T-cell inﬁltration and with a decrease in
clinical response after intradermal challenge with VZV antigen
(Figure 2c and Supplementary Figure S2 online), conﬁrming
previous observations (Agius et al., 2009; Vukmanovic-Stejic
et al., 2013). This is indirect evidence that these cells in older
subjects have suppressive activity.
We next investigated global gene expression proﬁles in the
skin of young and old subjects. Transcriptional analysis was
performed on skin biopsies of normal skin collected from
seven young and seven old healthy individuals. Overall,
unsupervised clustering coupled with bootstrapping did not
identify stable clusters separating skin samples from young
and old individuals (Figure 2d and Supplementary Figure S3A
online). Only two genes were considered differentially
expressed LPPR4 (higher in young) and ADAMTSL1 (higher
in old), using a typical false discovery rate (FDR)o0.05 and
fold change (FCH)42. In terms of pathways, Gene Set
Variation Analysis suggested differences in human skin
pigmentation genes and cell cycle–related genes (Wang
et al., 2013) but not in terms of immune genes, positive or
negative regulators, or in any of the skin-speciﬁc cytokine
pathways that we have curated (Suarez-Farinas et al., 2011;
Supplementary Figure S2C online).
Next, the global gene expression proﬁles in the young and
aged skin samples were compared with a large collection of
microarray data sets from distinct human primary cell popu-
lations (745 individual data sets; Mabbott et al., 2013). Data
were analyzed using Biolayout Express3D with a Pearson’s
correlation r=0.90 and Markov cluster algorithm of 2.2, and
140 clusters of ⩾6 probe sets (genes) were generated. The
network graph’s structure is derived from the clustering of
genes that are expressed in a cell- or function-speciﬁc manner
(Supplementary Figure S3D and Table S1 online), and their
contents reﬂect the nature of the cell populations represented
in human skin. Congruent with the differential transcriptional
analyses presented above (Supplementary Figure S3B and
S3C online), no signiﬁcant difference was observed in the
expression levels of the genes within these cell-speciﬁc
(e.g., keratinocytes, endothelium) and cellular activity–related
clusters (e.g., extracellular matrix, major histocompatibility
complex genes) between the two age groups (Supplementary
Figure S3E online).
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Effect of age on the extent of differentiation of CD4 T cells in
blood and skin
We investigated whether the T cells in skin were true skin-
resident T cells as deﬁned by CD69 expression, which is a
marker for tissue retention(Gebhardt et al., 2009; Clark et al.,
2012; Jiang et al., 2012; Skon et al., 2013). In contrast to
circulating T cells, 80–90% of skin-derived CD4 (Figure 3a
and b) and CD8 populations (data not shown) express CD69.
In addition, only around 10% of skin-derived cells express
CCR7, conﬁrming that the vast majority of cutaneous
T cells are skin resident and not transient T-cell populations
(Gebhardt et al., 2009; Clark et al., 2012; Jiang et al., 2012).
Furthermore, CD69+ T cells did not express surface CD25,
suggesting that they were not an activated population; this
was also conﬁrmed by their small size, deﬁned by forward
and side scatter properties by ﬂow cytometry. There was no
signiﬁcant change in the proportion of CD69+ cells with age
(Figure 3b).
To determine whether excessive differentiation toward an
end stage could reﬂect altered T-cell function in the skin
compared with T cells in peripheral blood, we collected
paired blood and skin samples from young and old
individuals (n=23 old and n= 31 young for CD4; n= 10
old and 14 young for CD8). On the basis of their expression of
surface CD45RA, CD27, CD4 (Figure 3c and d), and CD8
(Supplementary Figure S4A and S4B online) T cells from both
blood and skin can be subdivided into 4 subsets. The
CD45RA+CD27+ population is the least differentiated and
has the longest telomeres; CD45RA−CD27+ cells have inter-
mediated telomere lengths, whereas both CD45RA−CD27−
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Figure 1. Effect of age on circulating varicella zoster virus (VZV)-speciﬁc CD4+ T cells. (a) FACS analysis of intracellular IFN-γ staining following overnight
stimulation with VZV viral lysate in the presence of brefeldin A. Representative dot plots of the CD4+ IFN-γ response from a young donor are shown, as well as
unstimulated control. Cumulative data for all donors are plotted as increasing age (years) on the x axis against the percentage of antigen-speciﬁc IFN-γ+ CD4+
T cells. Line of best ﬁt was generated by linear regression and the correlation was assessed with Spearman’s rank correlation. (b) PBMCs were stimulated with a
range of doses of VZV lysate, and cell proliferation was measured on day 7. (c) PBMCs from young and old individuals were stimulated with VZV lysate for
72 hours and then stained for the expression of Ki67, CD4, and CD8 and analyzed by FACS. Data are expressed as % of CD4+ or CD8+ T cells expressing Ki67
above background (unstimulated PBMCs) (n=20 young and old; the horizontal line represents the mean). (d) The number of antigen-speciﬁc CD4+ cells was also
determined by class II tetramer staining. PBMCs were stained with HLA-DRB1*1501-restricted IE63 tetramer and with CLIP control (Jones et al., 2007;
Vukmanovic-Stejic et al., 2013). Each data point represents one individual (n= 5 young and old individuals; mean and SEM are indicated). PBMC, peripheral
blood mononuclear cell.
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and CD45RA+CD27− cells have relatively short telomeres
and express multiple other characteristics of senescence
(Di Mitri et al., 2011; Libri et al., 2011; Henson et al.,
2014). In both young and old subjects, cutaneous T cells in
both CD4+ (Figure 3c and d) and CD8+ populations
(Supplementary Figure S4A and S4B online) showed a
signiﬁcant decrease in the undifferentiated CD45RA+CD27+
population with a concomitant increase in CD27+CD45RA−
and CD45RA−CD27− cells. In older subjects, the proportion
of CD45RA−CD27− cells was signiﬁcantly higher within skin
CD4 and CD8 compartments compared with young subjects
(Figure 3).
We next investigated the functional capacity of skin-
resident T cells isolated from punch biopsies. Following a 6-
hour stimulation with PMA and ionomycin, cells were stained
for IL-2, IFN-γ, tumor necrosis factor-α, and IL-22. There were
no signiﬁcant differences in the capacity of CD4+ (Figure 3e
and f) or CD8+ T cells from the skin of young and old
individuals to secrete these inﬂammatory cytokines after
stimulation in vitro (Supplementary Figure S4D online).
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Figure 2. Effect of age on the skin-resident populations and gene expression proﬁles. Punch biopsies (5 mm) were collected from normal skin of healthy young
(o40 years old) and old (470 years old) volunteers. (a) Sections were stained to detect CD4, CD8, CD3, CD163, CD11c, and Foxp3 (scale bar = 100 μm). Cell
numbers were expressed as the mean absolute number of cells counted within the section. The frequency of Foxp3+CD4+ cells was conﬁrmed by 3-color IF
staining (DAPI: blue; CD4: green; and Foxp3: red; scale bar = 10 μm). (b) Graph shows numbers of different cell populations in young and old skin (n=5–7
young and old). Biopsies were collected following intradermal challenge with VZV antigen and stained for CD4 and Foxp3. Numbers of cells were counted in
perivascular inﬁltrates (the average of ﬁve largest perivascular inﬁltrates (PV) was calculated). Graph shows an inverse correlation between the proportion of
Foxp3+ cells within the CD4 population and a size of the cellular inﬁltrate (c) (ﬁlled circles: young; open circles: old). (d) Unsupervised clustering of the skin
samples from young (labels in red) and old (labels in blue) individuals based on the expression proﬁles using Affymetrix HG U133 Plus 2.0 arrays. VZV, varicella
zoster virus.
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VZV-speciﬁc skin-resident T cells in young and old subjects
We next investigated the phenotypic and functional char-
acteristics of VZV-speciﬁc T cells in both the skin and blood
of young and old subjects. Skin T cells isolated from
punch biopsies, and paired blood samples, were tested for
their ability to synthesize IFN-γ, tumor necrosis factor-α,
and/or IL-2 after overnight restimulation with VZV lysate as
previously described (Vukmanovic-Stejic et al., 2013).
Minimal IFN-γ or IL-2 was produced by blood or skin CD4+
T cells in the control cultures without VZV antigens (not
shown). We could identify cytokine-producing CD4+ cells in
the skin of 460% of young and old individuals tested
(positive staining for one or more cytokines, Figure 4a). In
those individuals in whom VZV-speciﬁc cells were found in
both compartments, there were signiﬁcantly higher propor-
tions of these cells in the skin (Figures 4a and b, P= 0.001,
Wilcoxon paired test, n= 9 old and 15 young). The observed
difference was not accounted for by the difference in the
differentiation state of skin versus blood CD4 T cells, as there
was a signiﬁcantly increased proportion of VZV-speciﬁc cells
in skin compared with the circulating memory compartment.
When the proportion of cytokine-secreting VZV-speciﬁc
CD4+ cells was compared between the skin of young and
old individuals, no signiﬁcant difference was observed
(Figure 4c). Therefore, there is no obvious age-associated
reduction in the number of cytokine-secreting VZV-speciﬁc
CD4+ T cells in the skin.
We also investigated the characteristics of VZV-speciﬁc
CD4+ T cells in the skin that were identiﬁed by class II
tetramer binding. Paired samples of cells isolated from skin
biopsies and PBMCs were stained with an HLA-DRB1*1501-
restricted IE63 tetramer (Jones et al., 2007). The representative
tetramer staining is shown in Figure 4d (left panels). Increased
proportions of VZV-speciﬁc CD4+ T cells were detected in the
skin when compared with the blood in both old and young
individuals (Figure 4d, Wilcoxon paired test, P= 0.06 in
young n= 6; and P= 0.008 in the old; n= 5). The speciﬁcity
of tetramer staining was conﬁrmed as described above
(Vukmanovic-Stejic et al., 2013). Therefore, using either
intracellular cytokine staining or tetramer binding, we found
higher proportions of VZV-speciﬁc CD4+ T cells in the skin
than in the blood of both young and old individuals; however,
there were no differences between the age groups in either
compartment.
We next compared the differentiation state of skin-resident
VZV-speciﬁc CD4+ T cells between young and old indivi-
duals. Overall, VZV-speciﬁc cells identiﬁed in the skin are
predominantly of the CD45RA−CD27+ and CD45RA−CD27−
phenotype (Figure 4e), similar to that seen in blood (Supple-
mentary Figure S5 online) in both age groups. Furthermore,
there was a signiﬁcant increase in CD45RA+CD27− T cells,
which have characteristics of end-stage differentiation or
senescence (Di Mitri et al., 2011; Libri et al., 2011; Henson
et al., 2014) within the VZV-speciﬁc population in old
compared with young skin. The phenotype of tetramer-
positive cells in skin was similar to that observed when
cytokine-secreting VZV-speciﬁc cells were analyzed (Supple-
mentary Figure S5C online). In conclusion, VZV-speciﬁc
CD4+ T cells in the blood and skin are functional and are not
restricted by excessive differentiation.
Expression of PD-1 in skin during aging
As the numbers of skin-resident VZV-speciﬁc CD4+ T cells are
not decreased during aging and they are able to secrete
cytokines in response to VZV antigen challenge in vitro, other
factors may contribute to the impaired skin recall response to
VZV antigen challenge in older subjects and to their increased
susceptibility to shingles (Levin et al., 2003; Agius et al., 2009;
Weinberg et al., 2010; Tang et al., 2012). The progressive loss
of cytokine production and proliferative activity by CD4+
T cells as a result of chronic immune stimulation during
persistent viral infections and cancer is associated with the
expression of PD-1 and other inhibitory receptors (Zajac et al.,
1998; Wherry, 2011). Blockade of these receptors can reverse
these functional defects in these cells (Kamphorst and Ahmed,
2013). We therefore investigated whether there was increased
expression of the T-cell surface inhibitory receptor PD-1 in
blood compared with skin cells during aging. Paired blood
and normal skin samples stained for the expression of PD-1 on
CD4+ (n= 17; 6 young, 6 middle aged, 5 old) and CD8+
T cells (n=−12; 4 young, 3 middle aged, 5 old). (Figure 5a
and b). There was a highly signiﬁcant increase in PD-1
expression on skin-resident compared with circulating T cells
(Po0.001, Wilcoxon paired test). PD-1 expression was
increased in both blood and skin during aging (Figure 5c)
with as many as 40% of CD4+ T cells being positive in
the skin. These data suggest that T cells in the skin of old
humans may be more susceptible to inhibition through PD-1
signalling.
DISCUSSION
Recent studies have shown that skin Trm cells have an
important role in providing protection against reexposure to,
or reactivation of, local persisting pathogens (Gebhardt et al.,
2009; Masopust et al., 2010; Tang and Rosenthal, 2010; Clark
et al., 2012; Cuburu et al., 2012; Mackay et al., 2012; Mueller
et al., 2013). Furthermore, these Trm cell populations may be
regulated independently of the circulating memory T-cell
Table 1. Numbers of different cell populations is
normal skin
Cell type
Marker
used
Range and
mean (young)
Range and
mean (old) different
T cells CD3 44–201, 131.8 91–291, 160.6 no
CD4+ T cells CD4 66–145, 93.4 45–159, 103 no
CD8+ T cells CD8 11–74, 41.6 24–110, 52,2 no
Tregs Foxp3 1–17, 11.6 17–50, 32.8 0.0095
Dendritic cells CD11c 46–105, 73.5 33–83, 52.75 no
Macrophages CD163 95–326, 192.8 199–390,
278.2
no
PDC BDCA3 18–33, 27.4 13–41, 25.75 no
Abbreviations: Tregs, regulatory T cells; PDC, Plasmacytoid dendritic cells.
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pools (Gebhardt et al., 2011; Clark et al., 2012; Carbone
et al., 2013; Mueller et al., 2013; Schenkel et al., 2013).
Considering the skin manifestation of both primary and
secondary varicella disease, it is unusual that VZV-speciﬁc
T cells have only previously been studied in the peripheral
blood (Hayward and Herberger, 1987; Asanuma et al., 2000;
Patterson-Bartlett et al., 2007; Weinberg and Levin, 2010; van
Besouw et al., 2012). We ﬁrst investigated whether there was
a general decrease in the number or functional capacity of
skin-resident T cells in older subjects. On the basis of the
expression of CD69, which was expressed by almost all skin-
derived CD4 and CD8 T cells, together with the lack of CCR7
expression and the fact that skin biopsies were collected from
normal, unchallenged skin, we concluded that our skin-
derived cells represent a skin-resident population (Gebhardt
et al., 2009; Clark et al., 2012; Jiang et al., 2012; Skon et al.,
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Figure 3. Effect of age on the phenotype and function of skin-resident T cells. Punch biopsies measuring 5mm and peripheral blood samples were collected
from n=31 young and n= 23 old donors. (a) Representative FACS histograms showing ex vivo CD69 expression in CD4+ T cells in skin compared with the blood.
Comparison of percentages of PD-1-expressing CD4+ or CD8+ T cells between the skin and blood of the same donors (Po0.001 Wilcoxon paired test).
(b) Cumulative data showing percentages of CD69-expressing cells among blood- and skin-derived CD4+ T cells, stratiﬁed by donor age. Spearman’s correlation
was used to calculate the signiﬁcance and deviation from zero. (c) Skin cells and PBMCs were stained with CD4, CD45RA, and CD27 to identify four
differentiation subsets. Representative FACS staining of PBMCs (top panels) and skin-derived cells (bottom panels) from young and old donors is shown gated on
the CD3+CD4+ cells. (d) Bar chart shows cumulative data for young and old individuals. Statistical analysis of blood and skin populations was performed using a
paired t-test, and P-values are indicated where relevant. (e) Skin-derived leukocytes were stimulated for 5 hours with PMA and ionomycin in the presence of
brefeldin A and stained for CD4, IFN-γ, IL-2, TNF-α, and IL-22. Representative dot plots are shown, gated on CD4+ cells (NS, nonstimulated; PMA+Iono, PMA
and ionomycin). (f) Graphs show % of CD4+ cells staining positive for a particular cytokine (n=5–7 young and old for each cytokine). PBMC, peripheral blood
mononuclear cell; PMA, phorbol 12-myristate 13-acetate; TNF-α, tumor necrosis factor-α.
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2013). However, contribution of recirculating T cells
transiently patrolling the skin cannot be completely
discounted (Zhu et al., 2013). A key observation was that
there were signiﬁcantly more VZV-speciﬁc CD4+ T cells in
the skin compared with the blood in both young and old
individuals. As the skin contains more T cells compared with
the blood (Clark et al., 2006; Clark, 2010), the decrease in
VZV-speciﬁc T cells in the circulation during aging may not
represent a global decrease in the number of these cells
in vivo as they may simply have relocated to the skin. This
observation coupled with the fact that other methods of
evaluating VZV-speciﬁc T cells do not indicate a reduction of
these cells in the blood suggests that there may not be a
general defect of VZV-speciﬁc T-cell numbers or function
during aging.
We found no differences in the numbers of dendritic cells
and macrophages between the two age groups, and
transcriptional proﬁling of young and old normal skin did
not show any signiﬁcant differences in the genes involved in
mononuclear phagocyte function or immune responses.
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Therefore, the general skin microenvironment at a steady state
appears very similar in young and old individuals, suggesting
that the reduced recall response to antigen in the skin during
aging (Agius et al., 2009) probably occurs downstream of
antigen challenge.
We investigated whether Trm cells in the skin of older
humans were inhibited in situ, as this could explain why there
is a reduced recall response to VZV skin test antigen
challenge and also the predisposition to VZV reactivation
in vivo. We showed previously that Foxp3+ Tregs that are
identiﬁed in the skin are suppressive and there is a signiﬁcant
inverse correlation between the number of these cells present
and the size of the delayed-type hypersensitivity response
after VZV challenge ((Vukmanovic-Stejic et al., 2013) and
Figure 2c, Supplementary Figure S2 online). The increase in
Tregs during aging has also been observed in the blood of
normal subjects (Gregg et al., 2005; Vukmanovic-Stejic et al.,
2006) and has also been reported in the tissues of old mice
(Lages et al., 2008; Raynor et al., 2012). This supports the
possibility that the increase in Treg cell numbers and their
suppressive activity may contribute to decreased VZV-speciﬁc
responses in older subjects.
Signalling through PD-1 and other inhibitory receptors can
inhibit T-cell responses both in vitro and in vivo (Zajac et al.,
1998; Wherry, 2011). The blockade of these receptors can
reverse these functional defects in these cells and this has led
to the use of PD-1-blocking strategies in the treatment
of melanoma and other skin cancers (Flemming, 2012;
Kamphorst and Ahmed, 2013; Lu et al., 2014). In addition,
it has been shown recently that interplay between Tregs and
PD-1 signalling regulates immune responsiveness and the
control of viral infection in vivo (Penaloza-MacMaster et al.,
2014). We observed very high PD-1 expression on skin
compared with blood T cells that increased with age. This
suggests that inhibitory signalling by different mechanisms
may actively regulate immune responsiveness in the skin,
especially during aging. The reason for the increase in Treg
numbers or PD-1 expression in the skin during aging is
unclear. It has been shown previously that infection with
persistent viruses such as cytomegalovirus in humans can
induce PD-1 expression and it is possible that more of the old
subjects we have studied are cytomegalovirus-positive+
compared with the young cohort (Henson et al., 2014).
Alternatively, these changes may be linked to the increased
inﬂammation (inﬂammaging) that is observed in elderly
subjects (Franceschi et al., 2000).
Our studies highlight the importance of studying human
immunity in additional compartments to peripheral blood.
The availability of a vaccine (Zostavax) to prevent herpes
zoster in older subjects has reduced the incidence of shingles
in the elderly (Gershon, 2007; Levin et al., 2008; Weinberg
et al., 2009), although the efﬁcacy of the vaccine is only 38%
in the very old (480 years). This indicates that it is essential to
study the mechanisms that are responsible for the declin-
ing immunity during aging to rationalize ways by which
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immunity in general and vaccine responses in particular
could be improved in the elderly.
MATERIALS AND METHODS
Subjects
Healthy individuals who had a history of previous chickenpox
infection (n= 94, median age= 32.5 years, age range 20–92 years,
38 male and 56 female) were recruited for the study. Subjects were
grouped as young (o40 years old), middle aged (40–65 years old), or
old (460 years old). This work was approved by the Ethics
Committee of the Royal Free Hospital, London. All volunteers
provided written informed consent and study procedures were
performed in accordance with the Declaration of Helsinki Principles.
Individuals with a history of neoplasia, immunosuppressive dis-
orders, or inﬂammatory skin disorders and individuals on immuno-
suppressive medication were excluded. In some cases skin from
healthy individuals was obtained from donors undergoing routine
plastic surgery at Guy’s and St Thomas’ hospitals (approved by the
Institutional Review Board of Guy’s Hospital). To examine the clinical
response to VZV, healthy individuals were injected intradermally
with VZV skin test antigen from The Research Foundation for
Microbial Diseases of Osaka University (BIKEN) as described
previously(Agius et al., 2009; Vukmanovic-Stejic et al., 2011).
Skin biopsies
Punch biopsies (5 mm diameter) from the upper volar region of the
forearm were obtained from 30 young and 25 old volunteers.
Biopsies were frozen in optimal cutting temperature compound
(OCT, Bright Instrument Company, Huntingdon, UK). Sections of
6 μm thickness were cut and then ﬁxed in ethanol and acetone and
stored at − 80 °C. For functional analysis of skin cells, 5 mm punch
biopsies were digested overnight with 0.8 mgml− 1 of collagenase IV
(Sigma-Aldrich, Gillingham, UK) as described (Vukmanovic-Stejic
et al., 2013). For the analysis of the delayed-type hypersensitivity
response to VZV challenge, skin biopsies were collected at different
time points post injection, frozen, and used for histological analysis
(Agius et al., 2009).
PBMC preparation
Heparinized blood samples were collected from healthy volunteers
and patients with acute disease. PBMCs were prepared by density
centrifugation on Ficoll-Paque (Amersham Biosciences, Little Chal-
font, UK) and resuspended in complete medium.
Flow cytometric analysis
Multiparameter analysis of skin and blood T-cell phenotype was
performed on LSR II or BD Fortessa using FACS Diva software (both
BD Biosciences, Oxford, UK) and further analyzed using FlowJo
software (TreeStar, Ashland, OR) as previously described (Agius
et al., 2009; Vukmanovic-Stejic et al., 2013). PBMCs or skin cells
were stained with different combinations of antibodies including
CD3, CD4, CD8, CD45RA, CD28, CD27 (BD Biosciences) Ki67,
CLA, CCR7, and PD-1 (clone EH12.2H7; Biolegend, London, UK).
All surface staining was performed for 30 minutes on ice. Isotype
control staining and ﬂuorescence-minus-one controls were used to
set the quadrants. Ki67 staining (clone B56, BD Bioscience) was
performed by intracellular staining using the Foxp3 Staining Buffer
Set (Miltenyi Biotec, Bisley, UK). For intracellular cytokine staining,
cells were stimulated with VZV lysate (Virusys, Taneytown, MD) or
staphylococcal enterotoxin B as positive control and incubated for
15 hours at 37 °C, 5% CO2, in the presence of 5 μgml− 1 Brefeldin A
(Sigma-Aldrich). Unstimulated controls were always included.
Following stimulations, cells were stained for surface markers for
30 minutes at 4 °C, washed, ﬁxed, and permeabilized (Fix and Perm
Cell Permeabilisation Kit, Invitrogen, Paisley, UK) before staining for
IL-2, IFN-γ, and tumor necrosis factor-α (all from BD Biosciences).
Tetramer staining
Tetramer staining was performed as previously described using
DRB1*1501 iTAg major histocompatibility complex II tetramer
complexed to VZV IE63 peptide 24 (QRAIERYAGAETAEY; Beckman
Coulter, High Wycombe, UK); CLIP peptide (PVSKMRMATPLLMQA)
was used as a control (Jones et al., 2007; Vukmanovic-Stejic et al.,
2013). Brieﬂy, cells were ﬁrst incubated with 2 μgml− 1 HLA Class II
tetramers for 1–2 hours at 37 °C in the dark, washed in PBS, and then
stained for different surface markers as needed. We analyzed the
tetramer expression within the CD4+ T-cell subset by gating on the
lymphocytes and excluding B cells, monocytes, and dead cells (Via-
Probe-positive population, BD Biosciences, Oxford, UK).
Immunoﬂuorescence
Skin sections of 6 μm thickness collected from normal or VZV-
injected skin were blocked with Dako non-serum protein block for
20 minutes, followed by overnight incubation with primary
antibodies (biotin anti-human Foxp3 and mouse anti- human CD4)
at 4 °C, followed by incubation with strepCy3 and anti-mouse IgG1
Alexa Fluor 488 for 1 hour at room temperature as described
(Vukmanovic-Stejic et al., 2008). Cell numbers were expressed as the
mean absolute cell number per perivascular inﬁltrate where ﬁve
largest perivascular inﬁltrates present in the upper and mid dermis of
each section were counted (Vukmanovic-Stejic et al., 2008).
Immunohistochemistry
Skin sections from normal skin (n= 6 young, n= 6 old) were stained
with puriﬁed mouse anti-human CD3 antibody, puriﬁed mouse anti-
human CD8 antibody (both Dakocytomation, Ely, UK), puriﬁed
mouse anti-human CD4 and CD11c antibodies (BD Biosciences),
or puriﬁed mouse anti-human CD163 antibody (Acris, Herford,
Germany). Sections were counterstained using rabbit anti-mouse
horseradish–peroxidase-conjugated antibody (Dakocytomation) and
developed with chromagen 3’-diaminobenzidine tetrahydrochloride.
The number of positive cells per mm2 was counted manually using
computer-assisted image analysis (NIH Image 6.1; http://rsb.info.nih.
gov/nih-image).
Transcriptional analysis
Punch biopsies measuring 3mm were collected from young and old
individuals and immediately frozen in RNAlater and stored at –20 °C
until use. Tissues were homogenized and total RNA extracted using
the RNeasy Mini Kit (Qiagen, Manchester, UK). Target ampliﬁcation
and labelling was performed according to standard protocols using
the Nugen Ovation WB Kit. RNA was hybridized to Affymetrix
Human Genome U133 2.0 plus arrays. Affymetrix gene chips were
scanned for spatial artifacts using the Hirshlight package (Suarez-
Farinas et al., 2005). Gene expression measures were obtained using
the GCRMA algorithm (Wu and Irizarry, 2004). Group comparisons
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were made using the moderated t-test and P-values were adjusted for
multiple hypotheses using the Benjamini–Hochberg procedure.
Network analysis of the genes expressed within skin samples and
in various human cell populations was performed as described pre-
viously (Mabbott et al., 2013). Brieﬂy, human skin-punch microarray
data were combined with a large collection of other primary cell
gene expression data sets (745 individual microarray data sets),
available from the GEO database on the Affymetrix Human Genome
U133 Plus 2.0 expression array platform (GSE49910) and analyzed
using Biolayout Express3D software (Freeman et al., 2007). The graph
of these data was then explored to understand the signiﬁcance of the
gene clusters, identify those expressed by the young and old skin
samples, and their functional relationships with the other cell
populations represented.
Statistics
Statistical analysis was performed using GraphPad Prism version 6.00
for Windows (GraphPad Software, San Diego, CA). Nonparametric
tests were predominantly utilized as data sets were not normally
distributed. The Wilcoxon matched-pairs test or a paired t-test was
used when comparing two groups of matched data, and a two-tailed
Mann–Whitney test was used when comparing two unpaired groups.
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